Navigation Links
Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
Date:4/29/2008

PITTSBURGH, April 29 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Michael J. Monroe as senior vice president - Global Public Affairs and as a member of the company's senior leadership team. In this role, Monroe is responsible globally for executive, financial and employee communications; corporate branding/marketing; corporate media relations; Internet management, sponsorships and event planning. In addition, he oversees the strategic coordination of communications for the company, working closely with Mylan's operating and support units.

"Mike is a talented and experienced senior executive," said Mylan's Vice Chairman and CEO Robert J. Coury. "His broad-based background and understanding of international public affairs will serve Mylan well as we strengthen our strategic global communications activities. We are fortunate to have added someone of Mike's caliber to Mylan's senior leadership team."

Monroe served previously as executive vice president - Public Affairs and chief communications officer for KeyCorp, one of the nation's largest financial services companies. During his 30 year career, he also completed assignments of increasing responsibility at CIGNA Corporation, The American Express Company and AT&T Long Lines Division.

Monroe earned a bachelor's degree from Rutgers University, graduating magna cum laude. He also holds a master's degree in journalism from Columbia University.

He is a member of The Phi Beta Kappa Society, The Public Relations Seminar and The Wisemen. He has chaired the Public Affairs Council of The Financial Services Roundtable and is the former chair of The Conference Board's Communications Council.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Announces Final FDA Approval for Trandolapril Tablets
2. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
3. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
4. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
5. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
6. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
7. Mylan Restores Availability of Generic Levothyroxine in Florida
8. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
9. Mylan Declares Quarterly Preferred Stock Dividend
10. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
11. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update ... Puerto Rico , where the company manufactures ... Following a comprehensive onsite assessment, the ... temporary loss of power and minimal water damage due ... have resumed, and the company expects to return to ...
Breaking Medicine Technology: